Cargando…
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
The possibility to identify patients with spinal muscular atrophy through neonatal screenings has highlighted the need for clinical assessments that may systematically evaluate the possible presence of early neurological signs. The aim of this study was to use the Hammersmith Neonatal Neurological E...
Autores principales: | Pane, Marika, Donati, Maria Alice, Cutrona, Costanza, De Sanctis, Roberto, Pirinu, Matteo, Coratti, Giorgia, Ricci, Martina, Palermo, Concetta, Berti, Beatrice, Leone, Daniela, Ticci, Chiara, Sacchini, Michele, Cerboneschi, Margherita, Capasso, Anna, Cicala, Gianpaolo, Pera, Maria Carmela, Bravetti, Chiara, Abiusi, Emanuela, Vaisfeld, Alessandro, Vento, Giovanni, Tiziano, Francesco Danilo, Mercuri, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192449/ https://www.ncbi.nlm.nih.gov/pubmed/35522315 http://dx.doi.org/10.1007/s00431-022-04470-3 |
Ejemplares similares
-
Assessing floppy infants: a new module
por: Cutrona, Costanza, et al.
Publicado: (2022) -
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
por: Coratti, Giorgia, et al.
Publicado: (2021) -
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study
por: Pera, Maria Carmela, et al.
Publicado: (2023) -
Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
por: Pane, Marika, et al.
Publicado: (2022) -
Type I SMA “new natural history”: long‐term data in nusinersen‐treated patients
por: Pane, Marika, et al.
Publicado: (2021)